Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
The IASLC Pathology Committee Recommendations for the Use of Diagnostic Immunohistochemistry...
lungcanc
Bringing Lung Cancer Screening into Communities: An NHS Pilot Program’s Success
lungcanc
Mentorship and Travel Awards for Nursing and Allied Health at WCLC...
lungcanc
Lung Cancer Global Mortality Projections Skyrocket for Women
lungcanc
c-MET Antibody–Drug Conjugates: Misconceptions Corrected, Excitement Explained— An Interview with Dr....
lungcanc
Nuances of PET Interpretation in Thoracic Oncology: More Than Just Lung...
lungcanc
Lung Cancer Pathology Pioneer Dr. Adi Gazdar Dies at 81
lungcanc
The Changing the Landscape of Tobacco Products: Potential Effects of ENDS...
lungcanc
Uncommon Oncogenic Drivers in NSCLC
lungcanc
Diagnostic Oncology: Reports from the IASLC Pathology Committee
lungcanc
1
...
17
18
19
...
53
Page 18 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
